Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6701–6750 of 18417
on January 12, 2024, the Company received notice from Zahed Subhan that he was resigning as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors.
Effective JANUARY 16, 2024, NELSON W. GRIST resigned as a Director, Officer and CE0 of PERK INTERNATIONAL, INC.
Effective as of January 10, 2024, Wm. Barrett Wellman resigned from his positions as Chief Financial Officer and Secretary of CoJax Oil and Gas Corporation, a Virginia corporation (the “Company”).
effective immediately upon Mr. Guzy’s resignation from positions as Chief Executive Officer, Chairman of the Board and President, the Board appointed William R. Downs as Chief Executive Officer, President, and Chairman.
On January 10, 2024, Mr. Guzy resigned from Chief Executive Officer, President and Chairman of the Board positions.
Effective immediately upon Mr. Wellman’s resignation, the board of directors of the Company (the “Board”) appointed Jeffrey J. Guzy as the Company’s Chief Financial Officer, Secretary and Treasurer.
On December 7, 2023, the Board of Directors of AGSS resolved to appoint Jason Bovell as the Chief Financial Officer of AGSS and reassign Mike Goossen from Chief Financial Officer to Senior Controller.
Jason A. Amello resigned from his position as the Chief Financial Officer, principal financial officer and principal accounting officer of the Company, effective January 12, 2024, to pursue another opportunity.
unanimously appointed Charles Schoch as the Company’s interim Chief Financial Officer, principal financial officer and principal accounting officer, effective January 12, 2024.
On January 8, 2024, Mannatech, Incorporated (the "Company") and its Board of Directors (the "Board") were notified by David A. Johnson, the Company's Chief Financial Officer ("CFO"), of his resignation from his position effective January 22, 2024.
Landen Fredrick, the Company’s President and Chief Operating Officer, will serve as the CFO until such time as a permanent CFO is hired by the Company.
Mallorie Burak, President and Chief Financial Officer of the Company and its principal financial officer and principal accounting officer, resigned from her positions at the Company to pursue another professional opportunity, effective as of January 11, 2024
appointed Apoorv S. Dwivedi, 43, as the Executive Vice President and Chief Financial Officer
On January 8, 2024, Beacon Roofing Supply, Inc. (the “ Company ”) appointed Carmelo Carrubba, age 53, as the Company’s Interim Chief Financial Officer to be effective as of January 20, 2024, until a permanent CFO has been appointed.
As previously disclosed on a Form 8-K filed with the Securities and Exchange Commission on December 4, 2023, the Company announced the resignation of Frank A. Lonegro as the Company’s Executive Vice President and Chief Financial Officer, effective as of February 1, 2024.
As previously reported, Robert E. Claypoole succeeded Mr. Bihl as President and Chief Executive Officer of the Company on January 10, 2024.
As previously reported, Robert E. Claypoole succeeded Mr. Bihl as President and Chief Executive Officer of the Company on January 10, 2024.
Effective as of January 10, 2024, Dr. Neil Campbell resigned as President and Chief Executive Officer and a member of the Board of Directors (the “Board”) of Onconetix, Inc. (the “Company”).
On January 12, 2024, the Board appointed Dr. Ralph Schiess, the Company’s Chief Science Officer, to serve as the Company’s Interim Chief Executive Officer.
Effective January 8, 2024, Leonid Gontmakher resigned as Chief Executive Officer of 4Front Ventures Corp. (the “Company”).
Effective January 8, 2024, the Company promoted Andrew Thut to Chief Executive Officer of the Company.
The effective date of Mr. Wintrob’s cessation of service as chief executive officer of OCG and a member of the board of directors of OCG has been determined to be March 1, 2024.
On January 10, 2024, Simon Stadil tendered his resignation as Chief Financial Officer of LiqTech International, Inc. (the " Company "), effective as of April 10, 2024.
In connection with Mr. Talley’s appointment to President and Chief Executive Officer, Mr. Doug Cole resigned from the President and Chief Executive Officer roles of the Company, but still maintains his roles as Executive Chairman and Chief Financial Officer.
On December 11, 2023, M2i Global, Inc. (“the Company”) appointed Lieutenant General (Ret) Jeffrey W. Talley, age 64, as President and Chief Executive Officer of the Company.
Effective January 12, 2024, The Marygold Companies, Inc. (the “Company”) has accepted the resignation of Stuart P. Crumbaugh on the Company’s Board of Directors and as its chief financial officer.
Rongguo Wei 52 Chief Financial Officer
Additionally, on January 9, 2024, John “JT” Thatch has been appointed to the Chief Executive Officer of the Company.
Patrick L. Bridges, our Senior Vice President and Chief Financial Officer, informed us that he intends to retire in March 2024 after more than 17 years of service to us.
On January 12, 2024, Todd Telesz, age 52, accepted the position to succeed Mr. Bridges as our Senior Vice President and Chief Financial Officer effective January 29, 2024.
Mr. Hoffman succeeds Eliot M. Lurier, who passed away in December 2023
On January 9, 2024, the Company’s Board of Directors (the “Board”) appointed Lawrence R. Hoffman as Interim Chief Financial Officer of the Company effective January 11, 2024
Effective as of January 8, 2024, the Board appointed Dr. Steve Niu as the CFO of the Company, until the next annual meeting of the Company’s stockholders, and until his successor is elected and qualified or until his prior death, resignation or removal.
Effective as of January 8, 2024, Qiuping Lu resigned from her position as the CFO of Yijia Group Corp (the “Company”).
designated Mr. Ajay Kataria as the Company’s principal accounting officer
Effective January 12, 2024, the Company appointed Mr. Mark Marino as Chief Financial Officer.
Mr. Naushaza "Bobby" Molu informed the Company of his intention to resign as Executive Vice President and Chief Financial Officer
the Board appointed Alan Gahm as interim Chief Financial Officer of the Company, effective on January 11, 2024.
Mr. Kurada will cease to serve as Chief Financial Officer and Head of Strategy of the Company, effective January 11, 2024
On January 10, 2024, the Board of Directors (the “Board”) of SeaStar Medical Holding Corporation (the “Company”) appointed David Green, age 61, as the Company’s Chief Financial Officer, effective as of January 10, 2024.
On January 10, 2024, Flexsteel Industries, Inc. (the “Company”) announced that Michael J. Ressler has been promoted to assume the role of Chief Financial Officer, Treasurer & Secretary effective immediately.
On January 10, 2024, in connection with Derek P. Schmidt being appointed President, Jerald K. Dittmer is relinquishing his position as President and will continue to serve as the Chief Executive Officer.
J. Erik Fyrwald has been appointed CEO of the Company and has been appointed to serve as a director of the Board.
Mr. Franklin K. Clyburn, Jr. who is currently Chief Executive Officer (“CEO”) of the Company and a director of the Company’s Board of Directors (the “Board”), will cease to serve as CEO and a director of the Board, effective February 6, 2024.
On January 7, 2024, the board of directors (the “Board”) of XOMA Corporation, a Delaware corporation (the “Company”), appointed Owen Hughes, previously Interim Chief Executive Officer, to serve as the Company’s Chief Executive Officer and to continue serving as principal executive officer and a director, effective immediately.
Samar Kamdar, the Company’s current Chief Financial Officer, will transition out of his role, effective immediately.
On January 8, 2024, biote Corp. (the “Company”) appointed Robert Peterson as Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.
On January 5, 2024, George O'Leary tendered his resignation as Chief Financial Officer of HealthLynked Corp., a Nevada corporation (the “ Company ”) effective April 4, 2024.
David Roman was expected to depart from his position as president and chief executive officer of the Company, as part of the Company’s strategic realignment of resources and corporate restructuring, which departure became effective January 7, 2024.
the Company’s board of directors approved the appointment of Takeo Mukai, the Company’s chief financial officer, as the Company’s chief executive officer, which appointment became effective January 8, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.